Cargando…
Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder
Narcolepsy type 1 (NT1) is a lifelong sleep disorder, primarily characterized clinically by excessive daytime sleepiness and cataplexy and pathologically by the loss of hypocretinergic neurons in the lateral hypothalamus. Despite being a rare disorder, the NT1-related burden for patients and society...
Autores principales: | Giannoccaro, Maria Pia, Liguori, Rocco, Plazzi, Giuseppe, Pizza, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123964/ https://www.ncbi.nlm.nih.gov/pubmed/34007229 http://dx.doi.org/10.2147/NSS.S275931 |
Ejemplares similares
-
A practical guide to the pharmacological and behavioral therapy of Narcolepsy
por: Franceschini, Christian, et al.
Publicado: (2021) -
Autism Spectrum Disorder and Narcolepsy: A Possible Connection That Deserves to Be Investigated
por: Posar, Annio, et al.
Publicado: (2020) -
REM Sleep Behavior Disorder in Children With Type 1 Narcolepsy Treated With Sodium Oxybate
por: Antelmi, Elena, et al.
Publicado: (2021) -
Presynaptic Paraneoplastic Disorders of the Neuromuscular Junction: An Update
por: Giannoccaro, Maria Pia, et al.
Publicado: (2021) -
Hypothalamus and amygdala functional connectivity at rest in narcolepsy type 1
por: Ballotta, Daniela, et al.
Publicado: (2021)